NEW YORK (GenomeWeb) – Curetis said today that based on a performance evaluation for the newest version of its Unyvero ITI Implant and Tissue Infection Application Cartridge, it has marked the cartridge as conforming with previous CE-IVD Marking. The firms also plans to launch the new generation cartridge internationally in the third quarter of 2016.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.